Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $1.65 and traded as high as $1.70. BioRestorative Therapies shares last traded at $1.56, with a volume of 120,765 shares.
BioRestorative Therapies Price Performance
The stock has a 50 day moving average price of $1.65 and a two-hundred day moving average price of $1.58. The company has a market capitalization of $10.80 million, a price-to-earnings ratio of -0.76 and a beta of 63.02.
BioRestorative Therapies (OTCMKTS:BRTX – Get Free Report) last announced its earnings results on Tuesday, August 13th. The company reported ($0.50) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.56) by $0.06. BioRestorative Therapies had a negative net margin of 13,728.83% and a negative return on equity of 120.47%. The company had revenue of $0.09 million during the quarter, compared to the consensus estimate of $0.03 million. Sell-side analysts forecast that BioRestorative Therapies, Inc. will post -3.52 EPS for the current fiscal year.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.
Read More
- Five stocks we like better than BioRestorative Therapies
- What Are Dividends? Buy the Best Dividend Stocks
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- How is Compound Interest Calculated?
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.